Rankings
▼
Calendar
CERS Q2 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena
CERS
Cerus Corporation
$358M
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$45M
+16.0% YoY
Gross Profit
$25M
54.7% margin
Operating Income
-$4M
-8.5% margin
Net Income
-$6M
-12.8% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
+17.5%
Cash Flow
Operating Cash Flow
$401,000
Free Cash Flow
$360,000
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$185M
Total Liabilities
$135M
Stockholders' Equity
$50M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$45M
$39M
+16.0%
Gross Profit
$25M
$21M
+15.6%
Operating Income
-$4M
-$12M
+67.0%
Net Income
-$6M
-$13M
+56.5%
Revenue Segments
Product
$45M
89%
Government Contract
$5M
11%
Geographic Segments
North America
$31M
68%
Europe Middle East And Africa
$14M
30%
Other
$558,000
1%
← FY 2024
All Quarters
Q3 2024 →